Kite Pharma, Inc. Insider Trading for December 2016

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Kite Pharma, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of insider trading in Kite Pharma, Inc. for December 2016.

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Dec 29 2016	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Option Exercise	A	47.72	159,700	7,620,884	159,700
Dec 29 2016	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Grant	A	0.00	43,800	0	68,507	24.7 K to 68.5 K (+177.28 %)
Dec 29 2016	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Gift	G	0.00	66,000	0	1,607,750	1.7 M to 1.6 M (-3.94 %)
Dec 27 2016	KITE	Kite Pharma, Inc.	Tomasello Shawn	Chief Commercial Of ...	Option Exercise	A	46.09	38,500	1,774,465	38,500
Dec 27 2016	KITE	Kite Pharma, Inc.	Tomasello Shawn	Chief Commercial Of ...	Grant	A	0.00	10,600	0	60,235	49.6 K to 60.2 K (+21.36 %)
Dec 27 2016	KITE	Kite Pharma, Inc.	MOORE TIMOTHY L.	EVP, Technical Oper ...	Option Exercise	A	46.09	30,700	1,414,963	30,700
Dec 27 2016	KITE	Kite Pharma, Inc.	MOORE TIMOTHY L.	EVP, Technical Oper ...	Grant	A	0.00	8,400	0	58,400	50 K to 58.4 K (+16.80 %)
Dec 27 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	A	46.09	38,500	1,774,465	38,500
Dec 27 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Grant	A	0.00	5,600	0	20,695	15.1 K to 20.7 K (+37.10 %)
Dec 27 2016	KITE	Kite Pharma, Inc.	JENKINSON PAUL L	Chief Financial Off ...	Option Exercise	A	46.09	24,200	1,115,378	24,200
Dec 27 2016	KITE	Kite Pharma, Inc.	JENKINSON PAUL L	Chief Financial Off ...	Grant	A	0.00	6,600	0	6,600	0 to 6.6 K
Dec 27 2016	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Option Exercise	A	46.09	38,500	1,774,465	38,500
Dec 27 2016	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Grant	A	0.00	10,600	0	18,664	8.1 K to 18.7 K (+131.45 %)
Dec 27 2016	KITE	Kite Pharma, Inc.	Chang David D	EVP, R&D, Chief Med ...	Option Exercise	A	46.09	90,600	4,175,754	90,600
Dec 27 2016	KITE	Kite Pharma, Inc.	Chang David D	EVP, R&D, Chief Med ...	Grant	A	0.00	24,800	0	49,923	25.1 K to 49.9 K (+98.71 %)
Dec 27 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Option Exercise	A	46.09	90,600	4,175,754	90,600
Dec 27 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Grant	A	0.00	24,800	0	117,795	93 K to 117.8 K (+26.67 %)
Dec 22 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	50.86	716	36,416	15,095	15.8 K to 15.1 K (-4.53 %)
Dec 22 2016	KITE	Kite Pharma, Inc.	Tomasello Shawn	Chief Commercial Of ...	Sell	S	50.86	4,901	249,265	49,635	54.5 K to 49.6 K (-8.99 %)
Dec 22 2016	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Sell	S	50.86	936	47,605	8,064	9 K to 8.1 K (-10.40 %)
Dec 22 2016	KITE	Kite Pharma, Inc.	Chang David D	EVP, R&D, Chief Med ...	Sell	S	50.86	1,788	90,938	25,123	26.9 K to 25.1 K (-6.64 %)
Dec 22 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Sell	S	50.86	2,482	126,235	92,995	95.5 K to 93 K (-2.60 %)
Dec 22 2016	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Sell	S	50.86	3,493	177,654	24,707	28.2 K to 24.7 K (-12.39 %)
Dec 05 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	1,500	10,335	89,000
Dec 05 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	51.23	207	10,605	15,811	16 K to 15.8 K (-1.29 %)
Dec 05 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	50.68	1,293	65,529	16,018	17.3 K to 16 K (-7.47 %)
Dec 05 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	1,500	10,335	17,311	15.8 K to 17.3 K (+9.49 %)